Cancer research encompasses data across various scales, modalities, and resolutions, from screening and diagnostic imaging to digitized histopathology slides to various types of molecular data and clinical records. The integration of these diverse data types for personalized cancer care and predictive modeling holds the promise of enhancing the accuracy and reliability of cancer screening, diagnosis, and treatment. Traditional analytical methods, which often focus on isolated or unimodal information, fall short of capturing the complex and heterogeneous nature of cancer data. The advent of deep neural networks has spurred the development of sophisticated multimodal data fusion techniques capable of extracting and synthesizing information from disparate sources. Among these, Graph Neural Networks (GNNs) and Transformers have emerged as powerful tools for multimodal learning, demonstrating significant success. This review presents the foundational principles of multimodal learning including oncology data modalities, taxonomy of multimodal learning, and fusion strategies. We delve into the recent advancements in GNNs and Transformers for the fusion of multimodal data in oncology, spotlighting key studies and their pivotal findings. We discuss the unique challenges of multimodal learning, such as data heterogeneity and integration complexities, alongside the opportunities it presents for a more nuanced and comprehensive understanding of cancer. Finally, we present some of the latest comprehensive multimodal pan-cancer data sources. By surveying the landscape of multimodal data integration in oncology, our goal is to underline the transformative potential of multimodal GNNs and Transformers. Through technological advancements and the methodological innovations presented in this review, we aim to chart a course for future research in this promising field. This review may be the first that highlights the current state of multimodal modeling applications in cancer using GNNs and transformers, presents comprehensive multimodal oncology data sources, and sets the stage for multimodal evolution, encouraging further exploration and development in personalized cancer care.
This review article provides an in-depth analysis of the latest advancements in federated learning, privacy preservation, and uncertainty quantification in medical imaging. It also highlights current challenges and explores potential opportunities for improvement in these areas.
The advancements in data acquisition, storage, and processing techniques have resulted in the rapid growth of heterogeneous medical data. Integrating radiological scans, histopathology images, and molecular information with clinical data is essential for developing a holistic understanding of the disease and optimizing treatment. The need for integrating data from multiple sources is further pronounced in complex diseases such as cancer for enabling precision medicine and personalized treatments. This work proposes Multimodal Integration of Oncology Data System (MINDS)—a flexible, scalable, and cost-effective metadata framework for efficiently fusing disparate data from public sources such as the Cancer Research Data Commons (CRDC) into an interconnected, patient-centric framework. MINDS consolidates over 41,000 cases from across repositories while achieving a high compression ratio relative to the 3.78 PB source data size. It offers sub-5-s query response times for interactive exploration. MINDS offers an interface for exploring relationships across data types and building cohorts for developing large-scale multimodal machine learning models. By harmonizing multimodal data, MINDS aims to potentially empower researchers with greater analytical ability to uncover diagnostic and prognostic insights and enable evidence-based personalized care. MINDS tracks granular end-to-end data provenance, ensuring reproducibility and transparency. The cloud-native architecture of MINDS can handle exponential data growth in a secure, cost-optimized manner while ensuring substantial storage optimization, replication avoidance, and dynamic access capabilities. Auto-scaling, access controls, and other mechanisms guarantee pipelines’ scalability and security. MINDS overcomes the limitations of existing biomedical data silos via an interoperable metadata-driven approach that represents a pivotal step toward the future of oncology data integration.
The architectures of deep artificial neural networks (DANNs) are routinely studied to improve their predictive performance. However, the relationship between the architecture of a DANN and its robustness to noise and adversarial attacks is less explored, especially in computer vision applications. Here we investigate the relationship between the robustness of DANNs in a vision task and their underlying graph architectures or structures. First we explored the design space of architectures of DANNs using graph-theoretic robustness measures and transformed the graphs to DANN architectures using various image classification tasks. Then we explored the relationship between the robustness of trained DANNs against noise and adversarial attacks and their underlying architectures. We show that robustness performance of DANNs can be quantified before training using graph structural properties such as topological entropy and Olivier-Ricci curvature, with the greatest reliability for complex tasks and large DANNs. Our results can also be applied for tasks other than computer vision such as natural language processing and recommender systems.
Cancer presents a complex tapestry of biological, clinical, and molecular characteristics that collectively influence its diagnosis, progression, and treatment. This review article delves into the recent advancements in integrating multimodal oncology data, a pivotal aspect in the evolving field of digital pathology (DP). The complexity and heterogeneity of cancer, characterized by its multimodal nature, present significant challenges in diagnosis and treatment. Traditional methods of oncology data analysis often fall short of capturing the comprehensive landscape of cancer’s multifaceted characteristics. The advent of artificial intelligence, machine learning, and deep learning has marked a new era in multimodal learning. These technologies have revolutionized how oncologists and researchers understand and approach cancer, allowing for a more nuanced and detailed analysis. In this review article, we attempt to examine and present how DP enriches its methods and analysis with other data modalities, including clinical, radiological, and molecular information. We present opportunities and challenges of multimodal learning in oncology, highlighting the synergistic potential of combining various data types for improving cancer care with a focus on DP. Continuous innovation in multimodal data integration will be instrumental in transforming cancer diagnosis, treatment planning, prognosis, and post-treatment surveillance.